Clinical trial
A Phase 2 Dose Response Study of LY2484595 in Japanese Subjects
NCT01375075 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Dose Response Study of LY2484595 in Japanese Subjects
- Lead sponsor
- Eli Lilly and Company
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2011
- Completion date
- March 31, 2012
- Enrollment
- 165 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.